Derniers articles listés par NCBI PubMed sur les maladies inflammatoires du foie et des voies biliaires (en anglais)
Qu’est-ce que PubMed?
Pubmed est la Bibliothèque Nationale de Médecine américaine. Pubmed incorpore plus de 24 millions d’extraits de littérature biomédicale issus du service en ligne MEDLINE, de journaux et livres scientifiques. Les extraits incorporent parfois des liens vers les textes intégraux des articles ou vers les sites web des éditeurs. Ces documents sont des publications scientifiques relatant l’avancée de la recherche sur les maladies inflammatoires du foie et des voies biliaires. Ils sont relayés ici sur le site d’albi afin que les malades comme les professionnels de la santé se fassent une idée des thématiques d’études et des avancées de la recherche. Il faut bien comprendre que ces communications sont des résultats de recherches ponctuelles, qui doivent être validés par d’autres études, pour éventuellement déboucher sur des innovations thérapeutiques quelques années plus tard. Si vous êtes malade, il est évident que ces informations ne peuvent pas être prises en compte pour prendre l’initiative d’une quelconque modification de votre traitement, modification qui ne peut se faire que sous avis médical.
> création: PhDu, albi, le 15/10/2013
> rédaction: PhDu, albi, le 15/10/2013
What is PubMed?
PubMed is the US National Library of Medicine. PubMed comprises more than 24 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
pubmed
- Pediatric biliary disorders: Multimodality imaging evaluation with clinicopathologic correlation.
- The epidemiology of UK autoimmune liver disease varies with geographic latitude.
- Primary biliary cholangitis: treatment.
- Ketohexokinase inhibition improves NASH by reducing fructose-induced steatosis and fibrogenesis.
- Presence and type of decompensation affects outcomes in autoimmune hepatitis upon treatment with corticosteroids.
- Clinicohistological correlation of etiological spectrum of chronic liver disease diagnosed during noncirrhotic stages in children: Can need of liver biopsy be obviated?
- Autoimmune Hepatitis with Elevated Serum IgG4 Levels Have a High Prevalence of Cirrhosis at Diagnosis.
- Occupational hazard in an immunosuppressed patient.
- Linear Scleroderma and Primary Sclerosing Cholangitis: An Undescribed Association.
- Rodent models of cholestatic liver disease: a practical guide for translational research.
- A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA.
- Reply to: Inflammatory bowel disease, celiac disease, and primary sclerosing cholangitis: is there a link?
- Integrative computational approach identifies drug targets in CD4+ T-cell-mediated immune disorders.
- Is it time to spit? More evidence for the oral-gut-liver axis in liver disease.
- Geo-epidemiology and environmental co-variate mapping of primary biliary cholangitis and primary sclerosing cholangitis.
- Review article: safety of new biologic agents for inflammatory bowel disease in the liver.
- Fatal intracardiac and pulmonary arterial thromboembolic damage following ABO-incompatible living donor liver transplantation for autoimmune hepatitis: A case report.
- Lusutrombopag as a substitute for platelet transfusion for thrombocytopenia associated with chronic liver disease in a patient undergoing endoscopic spinal surgery: A case report.
- Herb-induced autoimmune-like hepatitis associated with Xiang-tian-guo (Swietenia macrophylla seeds): A case report and literature review.
- Is UDCA really a post-transplant panacea?
- Enoxacin upregulates microRNA biogenesis and downregulates cytotoxic CD8 T cell function in autoimmune cholangitis.
- Reply to: Diagnostic role of anti-dsDNA antibodies: do not forget autoimmune hepatitis.
- Diagnostic role of anti-dsDNA antibodies: do not forget autoimmune hepatitis.
- [Random survival forest: applying machine learning algorithm in survival analysis of biomedical data].
- Safety and efficacy of in vitro fertilisation in patients with chronic liver disease and liver transplantation recipients.
- Guideline review: British Society of Gastroenterology/UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis.
- Rapid Progression of Liver Fibrosis Induced by Acute Liver Injury Due to Immune-related Adverse Events of Atezolizumab.
- Anti-mitochondrial Antibodies in Patients with Dilated Cardiomyopathy.
- Alcoholic liver disease and autoimmune hepatitis: Sometimes a closer look under the surface is needed.
- A Case Report of Alloimmune Hepatitis after Direct-acting Antiviral Treatment in a Liver Transplant Patient.
- Hispanic Patients with Primary Biliary Cholangitis Have Decreased Access to Care Compared to Non-Hispanics.
- Expanded circulating peripheral helper T cells in primary biliary cholangitis: Tph cells in PBC.
- Spectrum of esophageal motility disorders in patients with liver cirrhosis.
- Rare immunofluorescence patterns of autoantibodies on HEp-2 cells defined by ICAP identify different autoimmune diseases in the absence of associated specificities: a Spanish multicentre study.
- Liver fat content might be an appropriate measure for estimation of cardiovascular disease risk in non-alcoholic steatohepatitis patients.
- Splenectomy Prior to Experimental Induction of Autoimmune Hepatitis Promotes More Severe Hepatic Inflammation, Production of IL-17 and Apoptosis.
- Enhanced neoplasia detection in chronic ulcerative colitis: the ENDCaP-C diagnostic accuracy study
- Reply to Li J., et al. Letter to the Editor.
- A Case of Autoimmune Hepatitis during Brodalumab Treatment for Psoriasis.
- Autoimmune hepatitis in practice, from diagnosis to complications: What is the role of imaging? A clinicoradiological review.
- Manganese and copper levels in patients with primary biliary cirrhosis and primary sclerosing cholangitis.
- Gut Microbiome: A Potential Modifiable Risk Factor in Biliary Atresia.
- Living vs deceased donor liver transplantation in cholestatic liver disease: An analysis of the OPTN database.
- Letter to the Editor: Imaging monitoring of primary sclerosing cholangitis patients.
- Primary Biliary Cholangitis and CREST Syndrome: A Rare, Overlapping Presentation With a Review of the Literature.
- Infliximab Drug-Induced Autoimmune Hepatitis in a Patient With Crohn's Ileocolitis.
- Surgical repair of hepatic hydrothorax caused by diaphragmatic fistula.
- Concurrent Langerhans Cell Histiocytosis and Autoimmune Hepatitis: A Case and Review of the Literature.
- Oral Vancomycin or Ursodeoxycholic acid for Pediatric Primary Sclerosing Cholangitis? The Uncontroversial Need for Randomized Controlled Trials.
- Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease.
- COVID-19 in Chronic Liver Disease and Liver Transplantation: A Clinical Review.
- Limitation of the simplified scoring system for the diagnosis of Autoimmune Hepatitis with acute onset.
- Treg-specific IL-2 therapy can reestablish intrahepatic immune regulation in autoimmune hepatitis.
- Altered gut microbial metabolism of essential nutrients in primary sclerosing cholangitis.
- Inflammatory bowel disease, celiac disease, and primary sclerosing cholangitis: is there a link?
- Prognostic factors for advanced colorectal neoplasia in inflammatory bowel disease: systematic review and meta-analysis.
- Acute Liver Rejection in a Multiple Myeloma Patient Treated with Lenalidomide.
- IFNγ is a Key Link between Obesity and Th1-Mediated AutoImmune Diseases.
- The Role of the Gut Microbiome in Liver Cirrhosis Treatment.
- Non-alcoholic steatohepatitis or autoimmune hepatitis? Sometimes a closer look under the surface is needed.
- Altered von Willebrand Factor (vWF) and ADAMTS13 Levels in Children With Cirrhosis and Extrahepatic Portal Hypertension.
- Factors associated with major radiological progression of primary sclerosing cholangitis in patients with inflammatory bowel disease.
- Tacrolimus as second-line therapy in acute severe autoimmune hepatitis.
- Primary Sclerosing Cholangitis as an Independent Risk Factor for Cytomegalovirus Infection after Liver Transplant.
- Editorial: serologic antibodies in primary sclerosing cholangitis - a tell-tale sign of compromised gut-liver immunity?
- Editorial: serologic antibodies in primary sclerosing cholangitis-a tell-tale sign of compromised gut-liver immunity? Authors' reply.
- Experimental Pharmacological Agents for the Treatment of Primary Biliary Cholangitis.
- Steroid-induced reconstitution of the biliary tree ravaged by IgG4-related disease.
- Immune-mediated drug-induced liver injury secondary to Omeprazole: A case report.
- Clinical characteristics of paediatric autoimmune hepatitis at a referral hospital in Sub Saharan Africa.
- Cell Death in Liver Diseases: A Review.
- Melatonin Protects Cholangiocytes from Oxidative Stress-Induced Proapoptotic and Proinflammatory Stimuli via miR-132 and miR-34.
- Association of soluble T cell immunoglobulin domain and mucin-3 (sTIM-3) and mac-2 binding protein glycosylation isomer (M2BPGi) in patients with autoimmune hepatitis.
- Systematic Review and Meta-Analysis of Thiopurine Metabolite Levels and Biochemical Remission in Autoimmune Hepatitis.
- Focal intrahepatic strictures: A proposal classification based on diagnosis-treatment experience and systemic review.
- Primary biliary cholangitis: pathogenic mechanisms.
- Metabolomics Profiling and Diagnosis Biomarkers Searching for Drug-Induced Liver Injury Implicated to Polygonum multiflorum: A Cross-Sectional Cohort Study.
- [A patient with relapsing-remitting multiple sclerosis who relapsed frequently and developed primary biliary cholangitis after pregnancy and discontinuation of fingolimod].
- Syphilis Hepatitis Presenting as a Mimic of Primary Biliary Cholangitis.
- Portal hypertension in primary biliary cholangitis: prevalence, natural history and histological correlates.
- Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment tool.
- Leflunomide-Induced Autoimmune Hepatitis in a Patient With Rheumatoid Arthritis.
- Gut microbiome directs hepatocytes to recruit MDSC and promote cholangiocarcinoma.
- Obeticholic acid is associated with improvements in AST-to-platelet ratio index and GLOBE score in patients with primary biliary cholangitis.
- The impact of primary sclerosing cholangitis or inflammatory bowel disease on cholangiocarcinoma phenotype, therapy, and survival.
- Diffuse xanthomas in a patient with primary biliary cholangitis and lipoprotein X.
- Incidence of de novo autoimmune hepatitis in children and adolescents with increased autoantibodies after liver transplantation: a meta-analysis.
- Autoimmune hepatitis: from immunopathogenesis to diagnostic and therapeutic innovation.
- Mechanisms of autoimmune hepatitis.
- Effectiveness and safety of obeticholic acid in a Southern European multicenter cohort of patients with primary biliary cholangitis and suboptimal response to ursodeoxycholic acid.
- Serum Leptin Serves as an Inflammatory Activity Marker and Predicts Steroid Response in Autoimmune Hepatitis.
- Cholangiopathy and biliary fibrosis in Cyp2c70-deficient mice are fully reversed by ursodeoxycholic acid.
- Reply to: "Both tacrolimus and mycophenylate mophetil should be considered second-line therapy for autoimmune hepatitis".
- Both tacrolimus and mycophenylate mophetil should be considered second-line therapy for autoimmune hepatitis.
- Primary biliary cholangitis.
- Immunoglobulin G4-associated autoimmune hepatitis with peripheral blood eosinophilia: a case report.
- Detection of Anti-kelch-like 12 and Anti-hexokinase 1 Antibodies in Primary Biliary Cholangitis Patients in China.
- Precise delivery of obeticholic acid via nanoapproach for triggering natural killer T cell-mediated liver cancer immunotherapy.
- Risk stratification in primary sclerosing cholangitis.
- Association of Anti-TNF Therapy With Increased Risk of Acute Cholangitis in Patients With Primary Sclerosing Cholangitis.
- Drug-Induced Liver Injury Caused by "Khat," an Herbal Stimulant.
- [A case of autoimmune hepatitis with tuberculosis caused by prednisolone from undeterminable enzyme-linked immunospot assay].
- Ubiquitously specific protease 4 inhibitor-Vialinin A attenuates inflammation and fibrosis in S100-induced hepatitis mice through Rheb/mTOR signalling.
- Recent updates on the management of autoimmune hepatitis.
- BRD4 inhibition and FXR activation, individually beneficial in cholestasis, are antagonistic in combination.
- Replication study and meta-analysis indicate a suggestive association of RUNX3 locus with primary biliary cholangitis.
- A Patient With AIRE Mutation Who Presented With Severe Diarrhea and Lung Abscess.
- Recent advances in the treatment of primary sclerosing cholangitis.
- The Role of Hepatocellular Carcinoma Surveillance in Autoimmune Hepatitis.
- Levels of serum IgG subclasses in patients with liver disease: A retrospective study.
- High levels of proinflammatory cytokines IL-6, IL-8, TNF-Α, IL-23, and IFN- in Tunisian patients with type 1 autoimmune hepatitis.
- Open challenges in the management of autoimmune hepatitis.
- IgG4-related autoimmune liver disease.
- Current understanding of primary biliary cholangitis.
- Role of Hepatitis E Virus Infection in North American Patients With Severe Acute Liver Injury.
- Long-term oral vancomycin for refractory inflammatory bowel diseases without Clostridium difficile infection: Lessons from primary sclerosing cholangitis.
- Management of primary biliary cholangitis: results from a large real-life observational study in France and Belgium.
- Recurrent Autoimmune Hepatitis and De Novo Autoimmune Hepatitis in the Liver Allograft.
- Sex-Dependent Effects on Liver Inflammation and Gut Microbial Dysbiosis After Continuous Developmental Exposure to Trichloroethylene in Autoimmune-Prone Mice.
- Investigational drugs in early phase development for biliary cholangitis.
- Decreased infiltration of CD4+ Th1 cells indicates a good response to ursodeoxycholic acid (UDCA) in primary biliary cholangitis.
- Efficacy and safety of anti-hepatic fibrosis drugs.
- [Autoimmune hepatitis following acute severe Epstein-Barr virus hepatitis].
- Organoids to model liver disease.
- Ursodeoxycholic acid and bezafibrate were useful for steroid-refractory, immune-related hepatitis: a case report.
- Administration of Human MSC-Derived Extracellular Vesicles for the Treatment of Primary Sclerosing Cholangitis: Preclinical Data in MDR2 Knockout Mice.
- Worse Response to Ursodeoxycholic Acid in Primary Biliary Cholangitis Patients with Autoimmune Hepatitis Features.
- EVALUATION OF PATIENTS WITH AUTOIMMUNE HEPATITIS IN A SPECIALIZED OUTPATIENT CLINIC IN SOUTHERN BRAZIL.
- Plasmapheresis improves chronic fatigue in patients with primary biliary cholangitis.
- Portal bifurcation reconstruction using own hepatic vein grafts due to portal vein anomaly of the living donor for the patient with portal vein thrombosis.
- INFLAMMATORY BOWEL DISEASE AND SOLID ORGAN TRANSPLANTATION.
- StatPearls
- Successful response of primary sclerosing cholangitis and associated ulcerative colitis to oral vancomycin may depend on brand and personalized dose: report in an adolescent.
- Primary biliary cholangitis with normal alkaline phosphatase: A neglected clinical entity challenging current guidelines.
- Liver involvement in rheumatic diseases.
- Bile Acid Profiles in Primary Sclerosing Cholangitis and their Ability to Predict Hepatic Decompensation.
- Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver disease.
- A Case of Candidal Infection of Large Biloma After CT-Guided Liver Biopsy Confirming Autoimmune Hepatitis.
- Clinical Characterization of Ulcerative Colitis in Patients with Primary Sclerosing Cholangitis.
- Organoids and spheroids as novel models for studying cholestatic liver injury and cholangiocarcinoma.
- Identification and characterization of dynamically regulated hepatitis-related genes in a concanavalin A-induced liver injury model.
- Comparison of Platelet Count Reduction in Patients awaiting Liver Transplantation with and without Primary Sclerosing Cholangitis: A Cohort Study.
- Ulcerative colitis with concomitant primary sclerosing cholangitis.
- Sleep disorder in patients with chronic liver disease: a narrative review.
- The association of histological progression with biochemical response to ursodeoxycholic acid in primary biliary cholangitis.
- Liver graft harbouring hydatid disease: how far can we extend our donor pool?
- Anti-centromere antibodies target centromere-kinetochore macrocomplex: a comprehensive autoantigen profiling.
- Liver toxicity as a limiting factor to the increasing use of immune checkpoint inhibitors.
- A different type of acute myocarditis: a case report of acute autoimmune myocarditis mediated by anti-PD-1 T lymphocyte receptor (pembrolizumab).
- Autoimmune Hepatitis in a Patient With Common Variable Immunodeficiency.
- Comment on "Clinical and Pathological Characteristics of Autoimmune Hepatitis with Acute Presentation".
- Validity of an Automated Algorithm to Identify Cirrhosis Using Electronic Health Records in Patients with Primary Biliary Cholangitis.
- Kratom induced severe cholestatic liver injury histologically mimicking primary biliary cholangitis: A case report.
- Liver disease in the older child.
- Characteristics, trends and Outcomes of Liver Transplantation for Primary sclerosing cholangitis in female vs male patients: An analysis from the European Liver Transplant Registry.
- Multisystem involvement Langerhans cell histiocytosis in an adult: A case report.
- Asymptomatic hepatic artery dissection early after living-donor liver transplantation with simultaneous splenectomy: two case reports.
- Liver transplant recipients have an increased risk of developing colorectal adenomas. Results from a retrospective study.
- Safety and efficacy of budesonide during pregnancy in women with autoimmune hepatitis.
- Patterns of Immune Dysregulation in Primary Immunodeficiencies: A Systematic Review.
- UDCA Decreases Incidence of Primary Biliary Cholangitis and Biliary Complications after Liver Transplant: A Meta-Analysis.
- Autoimmune Liver Disease in Patients With Sickle Cell Disease.
- Clinical significance of IgG antimitochondrial M2 antibody levels in primary biliary cholangitis: A single center study from China.
- Association between Circulating Growth Differentiation Factor 15 and Cirrhotic Primary Biliary Cholangitis.
- Expression of signal-transducing adaptor protein-1 attenuates experimental autoimmune hepatitis via down-regulating activation and homeostasis of invariant natural killer T cells.
- Characterization and prevalence of extraintestinal manifestations in a cohort of patients with inflammatory intestinal disease in Medellin, Colombia.
- The Gut Barrier, Intestinal Microbiota, and Liver Disease: Molecular Mechanisms and Strategies to Manage.
- Massive Extra- and Intrahepatic Lithiasis in a Young Patient: a Case of LPAC-Syndrome?
- Serum Matrix Metalloproteinase 7 Is a Diagnostic Biomarker of Biliary Injury and Fibrosis in Pediatric Autoimmune Liver Disease.
- Activation of Liver X Receptor α Sensitizes Mice to T-Cell Mediated Hepatitis.
- Exploratory Study of Autoantibody Profiling in Drug-Induced Liver Injury with an Autoimmune Phenotype.
- The Course of Ulcerative Colitis After Pediatric Liver Transplantation for Sclerosing Cholangitis.
- Varicella-zoster-virus vaccination of immunosuppressed children with inflammatory bowel disease or autoimmune hepatitis: A prospective observational study.
- Measurement of liver and spleen stiffness as complementary methods for assessment liver fibrosis in autoimmune hepatitis.
- Mesalazine induced autoimmune hepatitis in a patient with Crohn's disease.
- De novo and recurrent liver disease.
- FibroMeter scores for the assessment of liver fibrosis in patients with autoimmune liver diseases.
- IgG4-related sclerosing cholangitis- A great mimicker.
- [Increased neoplastic risks in ulcerative colitis associated with primary sclerosing cholangitis].
- Genetic risk scores identify genetic aetiology of inflammatory bowel disease phenotypes.
- Association of serum 25-hydroxyvitamin D levels with severe necroinflammatory activity and inflammatory cytokine production in type I autoimmune hepatitis.
- Regional variation and temporal trend of PBC epidemiology: a systematic review and meta-analysis.
- Improved markers of cholestatic liver injury in patients with primary biliary cholangitis treated with obeticholic acid and bezafibrate.
- Chronic cholangitides: Differential diagnosis and role of MRI.
- Quantitative assessment of disease severity of primary sclerosing cholangitis with T1 mapping and extracellular volume imaging.
- Pregnancy outcomes in women with liver disease: Is pregnancy safe? A cross-sectional study.
- Tacrolimus and mycophenolate mofetil as second-line treatment in autoimmune hepatitis: Is the evidence of sufficient quality to develop recommendations?
- Managing cognitive symptoms and fatigue in cholestatic liver disease.
- Elective staged proctocolectomy and living donor liver transplantation for colon cancer with sclerosing cholangitis-related ulcerative colitis: a case report.
- Changes in disease characteristics of primary biliary cholangitis: an observational retrospective study from 1982 to 2016.
- C/EBPα/miR-7 controls CD4+ T cell activation and function and orchestrates experimental autoimmune hepatitis in mice.
- Bifidobacterium animalis ssp. Lactis 420 Mitigates Autoimmune Hepatitis Through Regulating Intestinal Barrier and Liver Immune Cells.
- Risk of Colon Cancer and Recommended Surveillance Strategies in Patients with Ulcerative Colitis.
- Structural basis of tropifexor as a potent and selective agonist of farnesoid X receptor.
- Selected Patients with Unresectable Perihilar Cholangiocarcinoma (pCCA) Derive Long-Term Benefit from Liver Transplantation.
- Quality of life among patients with autoimmune hepatitis in remission: A comparative study.
- Letter: the role of PNPLA3 genotype in autoimmune hepatitis needs further verification.
- Novel case of percutaneous access of afferent limb of Roux-en-Y hepaticojejunostomy for biliary decompression and jejunoplasty in a patient with primary sclerosing cholangitis.
- Regulatory T Cells in Autoimmune Hepatitis: Unveiling Their Roles in Mouse Models and Patients.
- Identification of Novel Therapeutic Molecular Targets in Inflammatory Bowel Disease by Using Genetic Databases.
- Liver Transplantation and Inflammatory Bowel Disease: Breaking Barriers in a Low-income Country.
- Antigen presentation, autoantibody production, and therapeutic targets in autoimmune liver disease.